Cannara Biotech Inc (LOVE) — Cash Flow Reinvestment Rate
Cannara Biotech Inc (LOVE) has a Cash Flow Reinvestment Rate of 0.58x as of November 2025, reinvesting CA$4.62 Million (capex CA$4.62 Million ) from operating cash flow of CA$7.96 Million. Explore Cannara Biotech Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cannara Biotech Inc Cash Flow Reinvestment Rate (2023–2025)
Historical reinvestment intensity for Cannara Biotech Inc across 3 annual periods. Also explore total assets of Cannara Biotech Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Cannara Biotech Inc (2023–2025)
Year-by-year capital reinvestment analysis for Cannara Biotech Inc. For live market cap and broader valuation context, see Cannara Biotech Inc stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.62x | CA$12.31 Million | CA$20.01 Million | CA$6.36 Million | ▼ -48.1% |
| 2024 | 1.18x | CA$12.66 Million | CA$10.68 Million | CA$7.47 Million | ▼ -63.8% |
| 2023 | 3.27x | CA$19.36 Million | CA$5.91 Million | CA$9.88 Million | — |